A Mechanistic Site-Of-Action Model: A Tool for Informing Right Target, Right Compound, And Right Dose for Therapeutic Antagonistic Antibody Programs.
Georgi I. KapitanovJeffrey R. ChabotJatin NarulaMahua RoyHendrik NeubertJoe PalandraVahid FarrokhiJay S. JohnsonRobert WebsterHannah M. JonesPublished in: Frontiers Bioinform. (2021)